CCND1 and central nervous system cancer: Western blot analysis five days after transduction revealed an impaired expression of cyclinD1 in U343-MG and U373-MG glioma cells with knockdown of SOX2 when compared to cells transduced with the shLuc control vector, whereas cyclinE levels remained unaffected (Figure 3c).